Student undergoing ‘precautionary treatment’ for meningitis in Christchurch

A student at Queenspark Primary School in Christchurch is undergoing preventive treatment for meningitis.  (File photo).

Kelly Sikkema/Unsplash

A student at Queenspark Primary School in Christchurch is undergoing preventive treatment for meningitis. (File photo).

A student at Christchurch Primary School on preventative treatment for meningitis has prompted his school to alert parents.

Queenspark School has been informed that a pupil is on preventative treatment for meningitis, along with several pupils being treated for a flu-like illness, a message to parents said on Monday.

The school was following Department of Health advice to notify the community as a “precautionary measure”, principal Ross Willocks said.

Antibiotic treatment has been recommended for close contacts of those with meningococcal disease (which causes meningitis), Canterbury Medical Officer Matthew Reid said.

READ MORE:
* Gastro bug causing ‘violent vomiting’ hits schools in Christchurch
* Sydney teenager dies of meningitis and Covid-19 in hospital
* Coronavirus: Mt Roskill elementary student tests positive for Covid-19

Te Whatu Ora Canterbury (formerly Canterbury District Health Board) did not comment on the care of individual patients, but contacts of contacts were not at risk, Reid said.

Quick facts – meningitis:

  • Symptoms of viral and bacterial meningitis may be similar at first. Symptoms of bacterial meningitis are usually more severe.
  • Symptoms differ between adults and infants.
  • Joint pain, vomiting, fever and stiff neck are common. Infants may refuse to eat, have a mottled complexion and a high-pitched cry.
  • In some cases, meningitis can lead to permanent disability such as deafness, limb amputation, or brain damage.
  • Bacterial meningitis is caused by close personal contact, such as coughing, sneezing, and kissing.
  • Anyone experiencing similar symptoms is advised to seek immediate medical attention.
  • Viral meningitis is less serious than the other types. It is more common in young children and in people under the age of 40.

About Antoine L. Cassell

Check Also

IMU-838 treatment associated with low rate of confirmed disability worsening in relapsing MS

Recently reported interim data from the Phase 2 EMPhASIS trial (NCT03846219) of Immunic’s investigational agent, …